Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects

References

• Basheer L, Kerem Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid Med Cell Longev 2015:854015
   PubMed Web of Science ®Google Scholar
• Bear WL, Teel RW. (2000). Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res 20:3323–9
   PubMed Web of Science ®Google Scholar
• Bedada SK, Nearati P. (2015). Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers. Phytother Res 29:701–6
   PubMed Web of Science ®Google Scholar
• Ciolino HP, Wang TT, Yeh GC. (1998). Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res 58:2754–60
   PubMed Web of Science ®Google Scholar
• Cova D, De Angelis L, Giavarini F, et al. (1992). Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 30:29–33
   PubMed Web of Science ®Google Scholar
• Duan KM, Wang SY, Ouyang W, et al. (2012). Effect of quercetin on CYP3A activity in Chinese healthy participants. J Clin Pharmacol 52:940–6
   PubMed Web of Science ®Google Scholar
• Fong SY, Gao Q, Zuo Z. (2013). Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review. Evid Based Complement Alternat Med 2013:898261
   PubMed Web of Science ®Google Scholar
• Garg SK, Kumar N, Bhargava VK, Prabhakar SK. (1998). Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 64:286–8
   PubMed Web of Science ®Google Scholar
• Grimsley SR, Jann MW, Carter JG, et al. (1991). Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 50:10–5
   PubMed Web of Science ®Google Scholar
• Harris RZ, Jang GR, Tsunoda S. (2003). Dietary effects on drug metabolism and transport. Clin Pharmacokinet 42:1071–88
   PubMed Web of Science ®Google Scholar
• Hodek P, Trefil P, Stiborová M. (2002). Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139:1–21
   PubMed Web of Science ®Google Scholar
• Ioannides C. (2003). Drug-phytochemical interactions. Inflammopharmacology 11:7–42
   PubMedGoogle Scholar
• Ioannides C. (2002). Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32:451–78
   PubMed Web of Science ®Google Scholar
• Kato Y, Fujii T, Mizoguchi N, et al. (2000). Potential interaction between ritonavir and carbamazepine. Pharmacotherapy 20:851–4
   PubMed Web of Science ®Google Scholar
• Kerr BM, Thummel KE, Wurden CJ, et al. (1994). Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 47:1969–79
   PubMed Web of Science ®Google Scholar
• Macphee GJ, Mitchell JR, Wiseman L, et al. (1988). Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man. Br J Clin Pharmacol 25:59–66
   PubMed Web of Science ®Google Scholar
• Middleton E, Jr Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751
   PubMed Web of Science ®Google Scholar
• Moon YJ, Wang X, Morris ME. (2006). Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20:187–210
   PubMed Web of Science ®Google Scholar
• Pari L, Srinivasan S. (2010). Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother 64:477–81
   PubMed Web of Science ®Google Scholar
• Pattanaik S, Hota D, Prabhakar S, et al. (2009). Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytother Res 23:1281–6
   PubMed Web of Science ®Google Scholar
• Quintieri L, Palatini P, Nassi A, et al. (2008). Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. Biochem Pharmacol 75:1426–37
   PubMed Web of Science ®Google Scholar
• Rajnarayana K, Reddy MS, Krishna DR. (2003). Diosmin pretreatment affects bioavailability of metronidazole. Eur J Clin Pharmacol 58:803–7
   PubMed Web of Science ®Google Scholar
• Romano B, Pagano E, Montanaro V, et al. (2013). Novel insights into the pharmacology of flavonoids. Phytother Res 27:1588–96
   PubMed Web of Science ®Google Scholar
• Shahzadi A, Javed I, Aslam B, et al. (2011). Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. Pak J Pharm Sci 24:63–8
   PubMed Web of Science ®Google Scholar
• So EL, Ruggles KH, Cascino GD, et al. (1994). Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide. Ann Neurol 35:743–6
   PubMed Web of Science ®Google Scholar
• Spina E, Arena D, Scordo MG, et al. (1997). Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy. Ther Drug Monit 19:535–8
   PubMed Web of Science ®Google Scholar
• Teel RW, Huynh H. (1998). Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett 133:135–41
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Horie M, Honda H, et al. (2009). The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biol Pharm Bull 32:671–6
   PubMed Web of Science ®Google Scholar
• Van Rooyen GF, Badenhorst D, Swart KJ, et al. (2002). Determination of carbamazepine and carbamazepine 10,11-epoxide in human plasma by tandem liquid chromatography-mass spectrometry with electrospray ionisation. J Chromatogr B Analyt Technol Biomed Life Sci 769:1–7
   PubMed Web of Science ®Google Scholar
• Villa P, Cova D, De Francesco L, et al. (1992). Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. Toxicology 73:179–89
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. (1996). Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J Pharmacokinet Biopharm 24:475–90
   PubMedGoogle Scholar
• Xiao CQ, Chen R, Lin J, et al. (2012). Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants. Xenobiotica 42:173–8
   PubMed Web of Science ®Google Scholar
• Yamsani SK, Yamsani MR. (2014). Effect of silymarin pretreatment on the bioavailability of domperidone in healthy human volunteers. Drug Metabol Drug Interact 29:261–7
   PubMedGoogle Scholar